Comparison of Treatment of Melomental Fold Rhytides with Cross-Linked Hyaluronic Acid Combined with OnabotulinumtoxinA and Cross-Linked Hyaluronic Acid Alone

Custis, Trenton; Beynet, David; Carranza, Dafnis; Greco, Joseph F.; Lask, Gary; Kim, Jenny

doi:10.1111/j.1524-4725.2010.01741.x

Cited by 14 publications

(13 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Botulinum toxin injection, administered with or prior to dermal filler, appears to also significantly improve the aesthetic result of HA filler treatment of the nasolabial fold (NLF). Two studies, by Custis et al and Carruthers and Carruthers, found that concurrent botulinium toxin and HA dermal filler treatment appeared to prolong the duration of correction by 6.5 and 14 weeks, respectively, compared to the treatment of HA dermal filler alone 6,10,11…”

Section: Methodsmentioning

confidence: 99%

Hyaluronic acid dermal fillers: can adjunctive lidocaine improve patient satisfaction without decreasing efficacy or duration?

Smith¹,

Cockerham²

2011

PPA

View full text Add to dashboard Cite

Hyaluronic acid (HA) dermal fillers are the most widely used injectables to augment facial volume without surgery. HA dermal fillers are popular because of their ease of administration, predictable effectiveness, good safety profile, and quick patient recovery. The most common patient complaint is pain. Our goal is to review the current literature on HA fillers and compare outcomes with and without lidocaine. We found adjunctive lidocaine significantly decreases pain during injection and postinjection with corresponding increased patient satisfaction. The efficacy and safety profile appears unchanged. Rare complications with HA fillers and those associated with constituents of the product, contaminants, and lidocaine are reviewed. The corrective effects of HA fillers are temporary; repeat treatment is required to maintain results. Minimizing pain is crucial to optimize patient satisfaction.

show abstract

Section: Methodsmentioning

confidence: 99%

Hyaluronic acid dermal fillers: can adjunctive lidocaine improve patient satisfaction without decreasing efficacy or duration?

Smith¹,

Cockerham²

2011

PPA

View full text Add to dashboard Cite

show abstract

“…6 Recent clinical trials demonstrated the efficacy and safety of combination therapy for lower facial rejuvenation, with better results than either modality alone. 56,57 Although there are limited data for treatment of the lower face and neck with botulinum toxin alone, 58–60 clinical use is well documented. On the basis of premeeting surveys, Figure 1 summarizes the panelists’ use of botulinum toxin alone, combined treatment with fillers, and fillers alone.…”

Section: Consensus Recommendationsmentioning

confidence: 99%

Global Aesthetics Consensus

Sundaram¹,

Signorini²,

Liew³

et al. 2016

Plastic and Reconstructive Surgery

165

View full text Add to dashboard Cite

Background:Botulinum toxin type A injection remains the leading nonsurgical cosmetic procedure worldwide, with a high rate of efficacy and patient satisfaction.Methods:A multinational, multidisciplinary group of plastic surgeons and dermatologists convened the Global Aesthetics Consensus Group to develop updated consensus recommendations with a worldwide perspective for botulinum toxin and hyaluronic acid fillers. This publication on botulinum toxin type A considers advances in facial analysis, injection techniques, and avoidance and management of complications.Results:Use of botulinum toxin has evolved from the upper face to also encompass the lower face, neck, and midface. The Global Aesthetics Consensus Group emphasizes an integrative, diagnostic approach. Injection dosage and placement are based on analysis of target muscles in the context of adjacent ones and associated soft and hard tissues. The indication for selection of botulinum toxin as a primary intervention is that excessive muscular contraction is the primary etiology of the facial disharmony to be addressed. Global Aesthetics Consensus Group recommendations demonstrate a paradigm shift toward neuromodulation rather than paralysis, including lower dosing of the upper face, more frequent combination treatment with hyaluronic acid fillers, and intracutaneous injection where indicated to limit depth and degree of action.Conclusions:The accumulation of clinical evidence and experience with botulinum toxin has led to refinements in treatment planning and implementation. The Global Aesthetics Consensus Group advocates an etiology-driven, patient-tailored approach, to enable achievement of optimal efficacy and safety in patient populations that are rapidly diversifying with respect to ethnicity, gender, and age.CLINCAL QUESTION/LEVEL OF EVIDENCE:Therapeutic, V.

show abstract

“…Recent comparative studies have established the safety and enhanced efficacy compared with solo treatment of combined treatments for lower face rejuvenation. 1,2 A 2008 North American consensus cited combination treatment as important for the lower face and sometimes appropriate for the upper face. 3 French consensus recommendations in 2011 4,5 and a panel of five experts from Canada, Europe, and South America in 2013 6 affirmed the value of the combined approach.…”

mentioning

confidence: 99%

Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A—Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations

Sundaram¹,

Liew²,

Signorini³

et al. 2016

Plastic &Amp; Reconstructive Surgery

114

View full text Add to dashboard Cite

show abstract

Comparison of Treatment of Melomental Fold Rhytides with Cross-Linked Hyaluronic Acid Combined with OnabotulinumtoxinA and Cross-Linked Hyaluronic Acid Alone

Abstract: Cross-linked HA and onabotulinumtoxinA combination therapy to melomental fold rhytides may provide better overall aesthetic results and longer duration of aesthetic improvement than cross-linked HA monotherapy.

Cited by 14 publications

References 10 publications

Hyaluronic acid dermal fillers: can adjunctive lidocaine improve patient satisfaction without decreasing efficacy or duration?

Hyaluronic acid dermal fillers: can adjunctive lidocaine improve patient satisfaction without decreasing efficacy or duration?

Global Aesthetics Consensus

Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A—Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations

Contact Info

Product

Resources

About